Eugia Pharma Receives USFDA Approval for Dexamethasone MDV 100 mg/10 mL
Published: June 07, 2019
Eugia Pharma Limited is pleased to announce that the company has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Dexamethasone Sodium Phosphate Injection USP, 100 mg/10mL (10 mg/mL) Multi-dose Vial.
Refer to package insert for full prescribing information.